Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 667

    1.

    A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.

    Bower M, Gazzard B, Mandalia S, Newsom-Davis T, Thirlwell C, Dhillon T, Young AM, Powles T, Gaya A, Nelson M, Stebbing J.

    Ann Intern Med. 2005 Aug 16;143(4):265-73. Erratum in: Ann Intern Med. 2006 Apr 18;144(8):620. PMID: 16103470 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Estimating outcome in patients with HIV-related lymphoma.

    [No authors listed]

    Ann Intern Med. 2005 Aug 16;143(4):I28. No abstract available. PMID: 16103466 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.

    Simcock M, Blasko M, Karrer U, Bertisch B, Pless M, Blumer L, Vora S, Robinson JO, Bernasconi E, Terziroli B, Moirandat-Rytz S, Furrer H, Hirschel B, Vernazza P, Sendi P, Rickenbach M, Bucher HC, Battegay M, Koller MT; Swiss HIV Cohort Study.

    Antivir Ther. 2007;12(6):931-9.PMID: 17926647 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.

    Robotin MC, Law MG, Milliken S, Goldstein D, Garsia RJ, Dolan GM, Kaldor JM, Grulich AE.

    HIV Med. 2004 Sep;5(5):377-84.PMID: 15369514 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.

    Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM.

    J Clin Oncol. 2005 Nov 20;23(33):8477-82. Epub 2005 Oct 17.PMID: 16230675 [PubMed - indexed for MEDLINE]Related articles

    6.

    Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.

    Vaccher E, Spina M, Talamini R, Zanetti M, di Gennaro G, Nasti G, Tavio M, Bernardi D, Simonelli C, Tirelli U.

    Clin Infect Dis. 2003 Dec 1;37(11):1556-64. Epub 2003 Nov 6.PMID: 14614680 [PubMed - indexed for MEDLINE]Related articles

    7.

    Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.

    Vaccher E, Tirelli U, Spina M, Talamini R, Errante D, Simonelli C, Carbone A.

    J Clin Oncol. 1996 Aug;14(8):2217-23.PMID: 8708710 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.

    Tam HK, Zhang ZF, Jacobson LP, Margolick JB, Chmiel JS, Rinaldo C, Detels R.

    Int J Cancer. 2002 Apr 20;98(6):916-22.PMID: 11948473 [PubMed - indexed for MEDLINE]Related articles

    9.

    Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.

    Hoffmann C, Wolf E, Fätkenheuer G, Buhk T, Stoehr A, Plettenberg A, Stellbrink HJ, Jaeger H, Siebert U, Horst HA.

    AIDS. 2003 Jul 4;17(10):1521-9.PMID: 12824790 [PubMed - indexed for MEDLINE]Related articles

    10.

    Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).

    Chow KU, Mitrou PS, Geduldig K, Helm EB, Hoelzer D, Brodt HR.

    Leuk Lymphoma. 2001 Mar;41(1-2):105-16.PMID: 11342362 [PubMed - indexed for MEDLINE]Related articles

    11.

    AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.

    Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM.

    J Clin Oncol. 2005 Jul 1;23(19):4430-8. Epub 2005 May 9.PMID: 15883411 [PubMed - indexed for MEDLINE]Related articles

    12.
    13.

    Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas.

    Lascaux AS, Hemery F, Goujard C, Lesprit P, Delfraissy JF, Sobel A, Lepage E, Lévy Y.

    AIDS Res Hum Retroviruses. 2005 Mar;21(3):214-20.PMID: 15795527 [PubMed - indexed for MEDLINE]Related articles

    14.

    Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).

    Wolf T, Brodt HR, Fichtlscherer S, Mantzsch K, Hoelzer D, Helm EB, Mitrou PS, Chow KU.

    Leuk Lymphoma. 2005 Feb;46(2):207-15.PMID: 15621803 [PubMed - indexed for MEDLINE]Related articles

    15.

    AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.

    Nasti G, Talamini R, Antinori A, Martellotta F, Jacchetti G, Chiodo F, Ballardini G, Stoppini L, Di Perri G, Mena M, Tavio M, Vaccher E, D'Arminio Monforte A, Tirelli U; AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive from Antiretrovirals.

    J Clin Oncol. 2003 Aug 1;21(15):2876-82.PMID: 12885804 [PubMed - indexed for MEDLINE]Related articles

    16.

    AIDS-related cancer and severity of immunosuppression in persons with AIDS.

    Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study.

    J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. Epub 2007 Jun 12.PMID: 17565153 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

    Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

    J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.PMID: 9048834 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.

    Stebbing J, Gazzard B, Mandalia S, Teague A, Waterston A, Marvin V, Nelson M, Bower M.

    J Clin Oncol. 2004 Jun 1;22(11):2177-83.PMID: 15169806 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.

    Zoufaly A, Stellbrink HJ, Heiden MA, Kollan C, Hoffmann C, van Lunzen J, Hamouda O; ClinSurv Study Group.

    J Infect Dis. 2009 Jul 1;200(1):79-87.PMID: 19476437 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors.

    Miralles P, Berenguer J, Ribera JM, Rubio R, Mahillo B, Téllez MJ, Lacruz J, Valencia E, Santos J, Rodríguez-Arrondo F, Pintado V; Grupo de Estudio del SIDA Register of Systemic AIDS-Related Lymphomas.

    J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):167-73.PMID: 17117144 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data